HomeHYL • EBR
add
Hyloris Pharmaceuticals SA
Previous close
€6.06
Day range
€5.84 - €6.00
Year range
€2.89 - €8.50
Market cap
166.31M EUR
Avg Volume
7.63K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.56M | 177.36% |
Operating expense | 3.72M | -36.04% |
Net income | -1.43M | 70.72% |
Net profit margin | -55.80 | 89.44% |
Earnings per share | — | — |
EBITDA | -1.05M | 78.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.15M | -21.86% |
Total assets | 41.34M | -13.31% |
Total liabilities | 9.19M | 6.73% |
Total equity | 32.14M | — |
Shares outstanding | 28.00M | — |
Price to book | 5.27 | — |
Return on assets | -7.37% | — |
Return on capital | -8.97% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.43M | 70.72% |
Cash from operations | -1.78M | 59.02% |
Cash from investing | -63.50K | -102.55% |
Cash from financing | -79.50K | -133.82% |
Net change in cash | -1.92M | -2.21% |
Free cash flow | -535.38K | 83.15% |
About
Founded
2012
Website
Employees
49
